Home

Conditioning Regimens for HSCT in AML/MDS

Balancing Strategies for Improved Outcomes EBAC

Fortezza Da Basso Congress Venue - Hall Cavaniglia 2

Sunday, 30 March 2025 | 16:30 - 18:00 CET

Supported by an independent educational grant from medac.

overview

Explore the latest advancements in conditioning regimens for hematopoietic stem cell transplantation (HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). This symposium offers a deep dive into the most recent clinical trial outcomes, providing insights into the efficacy of various regimens. Experts will discuss strategies for selecting the optimal regimen tailored to individual patient characteristics, focusing on enhancing therapeutic efficacy and patient safety. Additionally, the session will highlight practical approaches to integrating new data into everyday clinical practice, aiming to improve decision-making and patient outcomes in HSCT.

Important Information

This symposium will be offered both in-person and virtually at the 51st Annual Meeting of the EBMT, Florence, Italy.

Only registered attendees of EBMT can attend (This site is not for the EBMT Annual Meeting registration). This symposium will take place at the 51st Annual Meeting of the EBMT.

Enhance Your Experience With MedChallenge!

This event features MedChallenge, a new feature from Medscape that allows you to go head-to-head against your peers in a series of medical questions. Earn points, deepen your knowledge, and fight for the top spot on the leaderboard!

faculty

MODERATOR

Mohamad Mohty, MD, PhD

Professor and Department Head

Hematology and Cellular Therapy Department

Hospital Saint-Antoine Sorbonne University

Paris, France

PANELIST

Raynier Devillier, MD

Professor of Hematology

Hematology and Transplantation Unit

Paoli Calmettes Institut

Marseille, France

PANELIST

Friedrich Stölzel, MD

Professor of Medicine

Department Chair for Cell Transplantation and Cellular Therapies

University Hospital Schleswig-Holstein

Kiel, Germany

PANELIST

Filippo Milano, MD, PhD

Associate Professor

Director, Cord Blood Transplant Program

Clinical Research Division

Fred Hutchinson Cancer Center

Seattle, Washington, United States

AGENDA

16:30

Welcome and Introduction

Mohamad Mohty, MD, PhD

16:35

Setting the Stage: Decoding the Conditioning Spectrum

Mohamad Mohty, MD, PhD

16:40

The Conditioning Renaissance: New Data Reshaping Transplant Preparation

Friedrich Stölzel, MD

16:55

Half-Match, Full Potential: Optimizing Haploidentical HSCT with RTC Regimens

Raynier Devillier, MD

17:10

Bridging Insights: A US Perspective on Conditioning Regimens in HSCT

Filippo Milano, MD, PhD

17:25

Flip the Coin: RIC, RTC, or MAC?

All Faculty

17:55

Charting the Course: Future Horizons in Conditioning Regimens

Mohamad Mohty, MD, PhD

backstage pass

Enhance Your Virtual Experience With Backstage Pass! Backstage Pass provides an intimate virtual session where you can interact with faculty, address case-based questions, and facilitate relationship building.

*Video encouraged*

LOCATION

Fortezza Da Basso Congress Venue - Hall Cavaniglia 2

Viale Filippo Strozzi, 1 (access through Porta a Faenza), Florence, 50123 , Italy

TARGET AUDIENCE

This educational activity is intended for an audience of hematology/oncology specialists, transplant surgeons, and nurses in Europe.

GOAL STATEMENT

The goal of this activity is for learners to be better able to tailor conditioning regimens to patient characteristics using the latest advances in clinical knowledge.

LEARNING OBJECTIVES

Upon completion of this activity, participants will:[break] Have increased knowledge regarding the [LIST][ITEM]Characteristics of different conditioning regimens [ITEM]Impact of reduced-intensity conditioning (RIC) on patient outcomes[/LIST] [break] Demonstrate greater confidence in their ability to [LIST] [ITEM]Make clinical decisions for conditioning regimen selection[/LIST]

ACCREDITATION STATEMENT

WebMD Global LLC is an EBAC® accredited provider since 2024. [break][break] [bold]For Physicians[/bold][break] [break] This programme is accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) for 1.0 hours of external CE credit(s). Each participant should claim only those hours of credit that have actually been spent in the educational activity. [break][break] Total effective education time: 90 minutes. EBAC Activity ID #2024-EPN-7012000-000. [break][break] Through an agreement between the European Board for Accreditation of Continuing Education for Health Professionals and the American Medical Association (AMA), physicians may convert EBAC® CE credits to [bold][italic]AMA PRA Category 1 Credits™[/bold][/italic]. Information on the process to convert EBAC® credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™.

© 2024 MedscapeLIVE! All Rights Reserved | Medscape Education Terms of Service | Privacy Policy